SynopsisAdjuvant is an integral part of a vaccine that helps to develop strong immune response in the human body. Conventional vaccines are derived from toxin, inactivated whole organism, and live-attenuated, which are effective in stimulating antibody-based immunity......
SynopsisThe global Nanomaterial-Based Adjuvants Vaccine market was valued at US$ 59090 million in 2023 and is anticipated to reach US$ 40890 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030. Global key players of Nanomaterial-Based.....
Synopsis Due to the COVID-19 pandemic, the global Monitoring Electrodes market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully cons.....
SynopsisModified Sodium Hyaluronate Gel for Injection is a medical device commonly used in the field of aesthetic medicine. It is a gel-like substance made from modified sodium hyaluronate.Sodium hyaluronate is a naturally occurring substance in the human body that ha.....
SynopsisThe global Overactive Bladder (OAB) Bionic Drug market was valued at US$ 5029.3 million in 2023 and is anticipated to reach US$ 5345.8 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030. The global pharmaceutical market is 14.....
SynopsisWheeled Examination Lamp so constructed that an intense light is emitted through a slit; used for examination of the eye. The global Wheeled Examination Lamps market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witne.....
SynopsisThe global Avian Influenza Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. Pet medical care is the second largest segment in pet industry. In the .....
SynopsisPegfilgrastim is developed by PEGylating the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue, filgrastim. Pegfilgrastim was first launched by Amgen Inc. as Neulasta in 2002. Later, several biosimilars of pegfilgrastim were launched in .....
SynopsisThe global Kids Sports Injury Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, g.....
SynopsisCRYSVITA is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 6 months of age and older. Market Analysis and Insights: Global Crysvita Market The global Crysvita market was valued at US$ XX in 202.....
